Octave

🤔 Did you miss Dr. Stephen Krieger’s #AAN2024 presentation on 3D visualization of disease burden in multiple sclerosis? 💡No problem! 📽 Check out Dr. Krieger’s interview with Video Journal of Neurology (VJNeurology) where he shares how his Topographical Model has been combined with Octave’s MRI insights & 3D brain visualization tool to show individualized lesion burden for the first time! 🧠 📽 LINK: https://lnkd.in/gSAU3WSp 📚Read our poster: https://lnkd.in/gK_qC2Hj #MultipleSclerosis #TopographicalModel #3Dbrain #AAN

❓ Are you local to the San Francisco Bay Area and interested in Medical Imaging and AI? 💡Check out our partner Flywheel.io's upcoming Medical Imaging AI in 2040 meeting in Palo Alto, CA on Wednesday, June 12th where Octave's Kelly Leyden will discuss current and future applications of Using Multimodal Data to Improve Patient Outcomes. 📅 RSVP to join life sciences and healthcare leaders for a day of thought-provoking sessions and engaging networking with medical imaging peers: https://lnkd.in/d-5rBhxm We look forward to the discussions between industry thought leaders and attendees around building realistic frameworks for imaging data workflows, accelerating R&D by deploying AI at scale, and developing models with integrated platforms! #AI #imaging #medicalAI

Join us today at CMSC for our Supporter Showcase from 12:30 - 1:00 pm for a discussion with Jennifer Graves, MD, PhD, MAS, Taylor Gonyou, D.O., Julie Burnham, D.O. and Olaf Stuve, MD, PhD. Join our panelists to discuss how personalized medicine is possible for your MS patients. This session presents the Octave Multiple Sclerosis Disease Activity (MSDA) Test, which provides validated, actionable insights into disease activity. Explore crucial research and publications that demonstrate how this multi-protein biomarker approach enhances longitudinal patient management. See you there! Add to your calendar: https://lnkd.in/gyypXrnW #MultipleSclerosis #PrecisionCare #CMSC2024

Octave is proud to support World MS Day as we continue our mission to empower the proactive treatment of people living with Multiple Sclerosis through real-time clinically actionable data. This week our team is attending CMSC to present and understand the latest developments within MS research. #WorldMSDay #MSAwareness #MultipleSclerosis

📣🚨NEW Publication Alert 🚨📣 Octave is honored to announce that our latest peer-reviewed manuscript has been published in the prestigious journal, Nature Communications (Nature Portfolio)! The landmark manuscript titled “Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis” features several Octave studies with world-class cohorts including CLIMB from Brigham and Women's, EPIC from UCSF, and the Accelerated Cure Project Biorepository. These studies demonstrated that multiple proteins with diverse biological functions were found to have associations with multiple sclerosis endpoints of disease activity. In addition, the research indicates multi-protein models have stronger associations than any single protein models. Read the full manuscript here: https://lnkd.in/g5R3m39N Authors: Tanuja Chitnis, Ferhan Qureshi, Victor Gehman, Michael Becich, Riley Bove, Bruce A. C. Cree, Refujia Gomez, Stephen L. Hauser, Roland Henry, Amal Katrib, Hrishikesh Lokhande, Anu Paul, Stacy J. Caillier, Adam Santaniello, Neda Sattarnezhad, Shrishti S., Howard Weiner, Hajime Yano & Sergio Baranzini #MultipleSclerosis #Octave #MSResearch #PrecisionCare

Octave is at #CMSC2024 in Nashville! 👋 Visit us at Booth 511 to learn how we’re changing the paradigm of care in Multiple Sclerosis with our Precision Care Solution. Don't miss tomorrow's poster session & Friday's Supporter Showcase: 🗓 Thursday, May 30, 5:00 - 7:00 pm 📍 Location: Exhibit Hall AB ➡ Poster 1: 𝐈𝐦𝐩𝐫𝐨𝐯𝐢𝐧𝐠 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐎𝐮𝐭𝐜𝐨𝐦𝐞𝐬 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐚 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐂𝐚𝐫𝐞 𝐏𝐥𝐚𝐭𝐟𝐨𝐫𝐦 𝐢𝐧 𝐌𝐨𝐯𝐢𝐧𝐠-𝐌𝐒 - 𝐚 𝐂𝐚𝐬𝐞 𝐒𝐭𝐮𝐝𝐲 (Poster: CS19) 🔗 https://lnkd.in/gegk7xJz ➡ Poster 2: 𝐂𝐨𝐦𝐩𝐚𝐫𝐢𝐧𝐠 𝐍𝐞𝐮𝐫𝐨𝐫𝐚𝐝𝐢𝐨𝐥𝐨𝐠𝐢𝐬𝐭 𝐐𝐮𝐚𝐥𝐢𝐭𝐚𝐭𝐢𝐯𝐞 𝐑𝐚𝐭𝐢𝐧𝐠 𝐨𝐟 𝐀𝐭𝐫𝐨𝐩𝐡𝐲 𝐭𝐨 𝐍𝐨𝐫𝐦𝐚𝐭𝐢𝐯𝐞 𝐁𝐫𝐚𝐢𝐧 𝐕𝐨𝐥𝐮𝐦𝐞 𝐌𝐞𝐚𝐬𝐮𝐫𝐞𝐬 (Poster: IMG08) 🔗 https://lnkd.in/gm_ZJEc4 🗓 Friday, May 31, 12:30 - 1:00 pm 📍 Location: Exhibit Hall AB Showcase 1 ➡ Supporter Showcase: 𝐖𝐡𝐚𝐭’𝐬 𝐇𝐚𝐩𝐩𝐞𝐧𝐢𝐧𝐠? 𝐔𝐬𝐢𝐧𝐠 𝐚 𝐌𝐮𝐥𝐭𝐢-𝐏𝐫𝐨𝐭𝐞𝐢𝐧 𝐁𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫 𝐓𝐞𝐬𝐭 𝐟𝐨𝐫 𝐈𝐧𝐝𝐢𝐯𝐢𝐝𝐮𝐚𝐥𝐢𝐳𝐞𝐝 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐀𝐜𝐭𝐢𝐯𝐢𝐭𝐲 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 🔗 https://lnkd.in/gyypXrnW Learn more about what Octave is up to at CMSC ➡ https://lnkd.in/dhta7riD #MultipleSclerosis #MSCare #PrecisionCare

Attending CMSC 2024? Mark your calendar for the Octave Supporter Showcase on Friday, May 31 from 12:30 p.m. to 1:00 pm in Exhibit Hall AB Showcase 1. 🎤Join our panel to learn more about how the Octave Multiple Sclerosis Disease Activity (MSDA) test makes personalized medicine possible for #MultipleSclerosis patients with: Host: 👩⚕️ Jennifer Graves, MD, PhD, MAS ▪ Professor of Neurosciences, UC San Diego | Vice Chair of Human Clinical Research, UC San Diego | Division Chief, Neuroimmunology, UC San Diego | Director, Rady Children's Pediatric MS Center Panelists:  👩⚕️ Taylor Gonyou, D.O. ▪ Neurologist, Michigan Institute for Neurological Disorders Comprehensive MS Center 👩⚕️ Julie Burnham, D.O., D.O. ▪ President/Owner Michigan Neurology 👨⚕️ Olaf Stuve, MD, PhD ▪ Chief of Neurology, Dallas Veterans Affairs Medical Center | Head of MS/Neuroimmunology section | Professor - Department of Neurology UT Southwestern Medical Center Looking forward to hearing this incredible panel discuss the crucial research and publications that demonstrate how this multi-protein biomarker approach enhances longitudinal patient management! 💡Preview the session: https://lnkd.in/dhta7riD 🗓️ Add to your calendar: https://lnkd.in/gyypXrnW #MultipleSclerosis #PersonalizedMedicine #PrecisionCare  #Neurology #Biomarkers #CMSC2024

Meet the Octave team at CMSC 2024, May 29 - June 1! We are excited to connect and share how we’re changing the paradigm of care in #MultipleSclerosis with our #PrecisionCare Solution. Learn more about how Octave is bringing Precision Care Solutions to neurodegenerative diseases at the following #CMSC events: 📚Discover our science at the 2024 Poster Presentations in Exhibit Hall AB on Thursday, May 30, 5:00 - 7:00 pm ▪ Poster 1️⃣: Improving Patient Outcomes through a Comprehensive Care Platform in Moving-MS - a Case Study (Poster: CS19)  ▪ Poster 2️⃣: Comparing Neuroradiologist Qualitative Rating of Atrophy to Normative Brain Volume Measures (Poster: IMG08) 💡Join our Supporter Showcase to learn how The Octave Multiple Sclerosis Disease Activity (MSDA) Test makes personalized medicine possible for Multiple Sclerosis patients: 🗓 Friday, May 31, 12:30 - 1:00 pm  📍 Exhibit Hall AB Showcase 1 ➡️ Visit us at Booth 511 and schedule your meeting with the Octave team: https://lnkd.in/dhta7riD Look forward to seeing you there! #CMSC #PrecisionMedicine #MS #Neurology #MRI #Biomarkers #MultipleSclerosis

🎤 Octave’s Senior VP of Biomarker R&D, Ferhan Qureshi, sat down with Video Journal of Neurology (VJNeurology) to discuss Octave’s precision care solution and its use in an observational, real world study for MS patient management.  The study sponsored by Biogen is evaluating 150 patients with Multiple Sclerosis (#MS) at the Rocky Mountain Multiple Sclerosis Clinic, Oklahoma Medical Research Foundation (OMRF) Multiple Sclerosis Center of Excellence, and Orlando Health Multiple Sclerosis Comprehensive Care Center. Thank you to our authors: Dr. John Foley, Dr. Gabriel Pardo, MD, FAAN, Dr. Amparo (Amy) Gutierrez, Jason Mendoza, Ph.D., James Lewin, Robin Avila, Ph.D., Tammy Hoyt, Sarah Eagleman, Kelly Leyden, Danielle Siniscalchi, Ati Ghoreyshi and Ferhan Qureshi 💡 Learn more about about our findings & upcoming analysis outputs below! 📽 Watch now: https://lnkd.in/gZq2Kjt5 📚View the poster: https://lnkd.in/gnWRE_NR #Octave #NeurodegenerativeDisease #PrecisionCare #MultipleSclerosis

Octave has been recognized as the “Best Care Management Platform” in the 8th Annual MedTech Breakthrough award program. The recognition is a testament to our success in delivering actionable insights in a precision medicine solution for MS and our vision to redefine the standard of care for neurological diseases. Learn more: https://lnkd.in/eZeURjS4 #PrecisionMedicine #MultipleSclerosis #HealthcareInnovation